Skip to main content
Erschienen in: Obesity Surgery 1/2011

01.01.2011 | Clinical Research

Association of Body Mass Index and Lipid Profiles: Evaluation of a Broad Spectrum of Body Mass Index Patients Including the Morbidly Obese

verfasst von: Lior Shamai, Einar Lurix, Michael Shen, Gian M. Novaro, Samuel Szomstein, Raul Rosenthal, Adrian V. Hernandez, Craig R. Asher

Erschienen in: Obesity Surgery | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Prior epidemiologic studies have shown that increasing body mass index (BMI) is associated with higher total cholesterol and low-density lipoprotein cholesterol (LDL). However, these studies were limited by underrepresentation of obese subjects. The aim of this study was to determine whether there is an association between BMI and lipid profiles in a population of patients with a broad spectrum of BMI values. A case-control study was performed involving patients seen at the Cleveland Clinic Florida. Cases (BMI >30 kg/m2) were obtained from the obesity surgery database between August 31, 2000, and April 4, 2002. Controls (BMI ≤ 30 kg/m2) were obtained from a database of primary care physicians between May 1, 2004, and November 18, 2004. Pearson correlation coefficients were used to assess the relationship between BMI and lipid fractions. Multiple linear regression was performed to assess the independent effect of BMI on lipid levels while adjusting for potential confounders and propensity scores. Six hundred thirty-seven patients were analyzed (females, n = 362, 57%). There was no association between higher BMI and LDL (r = 0.19 p = 0.07), a negative association with high-density lipoprotein cholesterol (HDL; r = 0.45, p < 0.001), and a positive association with the log transformation of triglycerides (r = 0.32, p = 0.005).
Higher BMI was inversely associated with HDL and directly associated with TG. BMI showed no significant association with LDL. Although the association between BMI and both HDL and TG may be explained by insulin resistance, the lack of a significant association between BMI and LDL remains an unexpected finding that requires further investigation.
Literatur
1.
Zurück zum Zitat Krauss RM, Winston M, Fletcher BJ, et al. Obesity: impact on cardiovascular disease. Circulation. 1998;98:1472–6. Krauss RM, Winston M, Fletcher BJ, et al. Obesity: impact on cardiovascular disease. Circulation. 1998;98:1472–6.
2.
Zurück zum Zitat Després JP, Moorjani S, Tremblay A, et al. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein–lipid composition in premenopausal women. Clin Invest Med. 1989;12:374–80.PubMed Després JP, Moorjani S, Tremblay A, et al. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein–lipid composition in premenopausal women. Clin Invest Med. 1989;12:374–80.PubMed
3.
Zurück zum Zitat Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401–10.CrossRefPubMed Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401–10.CrossRefPubMed
4.
Zurück zum Zitat Nicholls SJ, Tuzcu EM, Sipahi I, et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). Am J Cardiol. 2006;97:1553–7.CrossRefPubMed Nicholls SJ, Tuzcu EM, Sipahi I, et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). Am J Cardiol. 2006;97:1553–7.CrossRefPubMed
5.
Zurück zum Zitat McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006;296:79–86.CrossRefPubMed McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006;296:79–86.CrossRefPubMed
6.
Zurück zum Zitat Drapeau V, Lemieux I, Richard D, et al. Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg. 2006;16:501–9.CrossRefPubMed Drapeau V, Lemieux I, Richard D, et al. Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg. 2006;16:501–9.CrossRefPubMed
7.
Zurück zum Zitat Anderson KM, Wilson PW, Garrison RJ, et al. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis. 1987;68:59–66.CrossRefPubMed Anderson KM, Wilson PW, Garrison RJ, et al. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis. 1987;68:59–66.CrossRefPubMed
8.
Zurück zum Zitat Newman B, Selby JV, Quesenberry CP, et al. Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health. 1990;80:675–8.CrossRefPubMed Newman B, Selby JV, Quesenberry CP, et al. Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health. 1990;80:675–8.CrossRefPubMed
9.
Zurück zum Zitat Bertsias G, Mammas I, Linardakis M, et al. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003;3–3. Bertsias G, Mammas I, Linardakis M, et al. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003;3–3.
10.
Zurück zum Zitat Kannel WB, Lebauer EJ, Dawber TR, et al. Relation of body weight to development of coronary heart disease: the Framingham Study. Circulation. 1967;35:734–44.PubMed Kannel WB, Lebauer EJ, Dawber TR, et al. Relation of body weight to development of coronary heart disease: the Framingham Study. Circulation. 1967;35:734–44.PubMed
11.
Zurück zum Zitat Howard BV, Knowler WC, Vasquez B, et al. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984;4:462–71.PubMed Howard BV, Knowler WC, Vasquez B, et al. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984;4:462–71.PubMed
12.
Zurück zum Zitat Uusitupa M, Siitonen O, Voutilainen E, et al. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diab Care. 1986;9:17–22.CrossRef Uusitupa M, Siitonen O, Voutilainen E, et al. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diab Care. 1986;9:17–22.CrossRef
13.
Zurück zum Zitat Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body Weight, Cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–9.PubMed Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body Weight, Cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–9.PubMed
14.
Zurück zum Zitat Reeder BA, Angel A, Ledoux M, et al. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ. 1992;146:2009–19. Reeder BA, Angel A, Ledoux M, et al. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ. 1992;146:2009–19.
15.
Zurück zum Zitat Rifkind BM, Begg T, Jackson ID. Relationship of plasma lipids and lipoproteins to obesity. Proc R Soc Med. 1966;59:1277–8.PubMed Rifkind BM, Begg T, Jackson ID. Relationship of plasma lipids and lipoproteins to obesity. Proc R Soc Med. 1966;59:1277–8.PubMed
16.
Zurück zum Zitat Angel A. Pathophysiologic changes in obesity. CMAJ. 2005;23:421–9. Angel A. Pathophysiologic changes in obesity. CMAJ. 2005;23:421–9.
17.
Zurück zum Zitat Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses arteriosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 1997;17:1082–90. Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses arteriosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 1997;17:1082–90.
18.
Zurück zum Zitat Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res. 2004;12:1914–20.CrossRefPubMed Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res. 2004;12:1914–20.CrossRefPubMed
19.
Zurück zum Zitat Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch of Int Med. 1993;153:1093–103.CrossRef Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch of Int Med. 1993;153:1093–103.CrossRef
20.
Zurück zum Zitat Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773–81.CrossRefPubMed Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773–81.CrossRefPubMed
21.
Zurück zum Zitat Onat A, Hergenc G, Sari I, et al. Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J. 2007;71:1463–7.CrossRefPubMed Onat A, Hergenc G, Sari I, et al. Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J. 2007;71:1463–7.CrossRefPubMed
22.
Zurück zum Zitat Hershcopf RJ, Elahi D, Andres R, et al. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chron Dis. 1982;35:101–14.CrossRefPubMed Hershcopf RJ, Elahi D, Andres R, et al. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chron Dis. 1982;35:101–14.CrossRefPubMed
23.
Zurück zum Zitat Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601–7.CrossRefPubMed Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601–7.CrossRefPubMed
24.
Zurück zum Zitat Weinbrenner T, Schröder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–5.PubMed Weinbrenner T, Schröder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–5.PubMed
25.
Zurück zum Zitat Dixon JB, O'Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord. 2001;25:793–7.CrossRefPubMed Dixon JB, O'Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord. 2001;25:793–7.CrossRefPubMed
26.
Zurück zum Zitat Vierhapper H, Nardi A, Grösser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607–10.CrossRefPubMed Vierhapper H, Nardi A, Grösser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607–10.CrossRefPubMed
27.
Zurück zum Zitat Rainwater DL, Mitchell BD, Comuzzie AG, Haffner SM. Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord. 1999;23:180–9.CrossRefPubMed Rainwater DL, Mitchell BD, Comuzzie AG, Haffner SM. Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord. 1999;23:180–9.CrossRefPubMed
28.
Zurück zum Zitat Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527–33.CrossRefPubMed Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527–33.CrossRefPubMed
29.
Zurück zum Zitat Goff DC, D'Agostino RB, Haffner SM, et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005;54:264–70.CrossRefPubMed Goff DC, D'Agostino RB, Haffner SM, et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005;54:264–70.CrossRefPubMed
30.
Zurück zum Zitat Saroja VV, Guowen C, Shelley CA, et al. Common set of genes regulates low-density lipoprotein size and obesity-related factors in Alaskan Eskimos: results from the GOCADAN study. Am J Hum Biol. 2006;18:525–31.CrossRef Saroja VV, Guowen C, Shelley CA, et al. Common set of genes regulates low-density lipoprotein size and obesity-related factors in Alaskan Eskimos: results from the GOCADAN study. Am J Hum Biol. 2006;18:525–31.CrossRef
Metadaten
Titel
Association of Body Mass Index and Lipid Profiles: Evaluation of a Broad Spectrum of Body Mass Index Patients Including the Morbidly Obese
verfasst von
Lior Shamai
Einar Lurix
Michael Shen
Gian M. Novaro
Samuel Szomstein
Raul Rosenthal
Adrian V. Hernandez
Craig R. Asher
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 1/2011
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0170-7

Weitere Artikel der Ausgabe 1/2011

Obesity Surgery 1/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.